Acute promyelocytic leukemia: where did we start, where are we now and the future
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Acute promyelocytic leukemia: where did we start, where are we now and the future
Authors
Keywords
-
Journal
Blood Cancer Journal
Volume 5, Issue 4, Pages e304-e304
Publisher
Springer Nature
Online
2015-04-17
DOI
10.1038/bcj.2015.25
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Outcomes and prognostic factors of first relapsed acute promyelocytic leukemia patients undergoing salvage therapy with intravenous arsenic trioxide and chemotherapy
- (2014) Yinjun Lou et al. ANNALS OF HEMATOLOGY
- Autologous Is Superior to Allogeneic Hematopoietic Cell Transplantation for Acute Promyelocytic Leukemia in Second Complete Remission
- (2014) Jennifer L. Holter Chakrabarty et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysis
- (2014) G N Mannis et al. BONE MARROW TRANSPLANTATION
- Arsenic trioxide during consolidation for patients with previously untreated low/intermediate risk acute promyelocytic leukaemia may eliminate the need for maintenance therapy
- (2014) Steven E. Coutre et al. BRITISH JOURNAL OF HAEMATOLOGY
- New Strategies in Acute Promyelocytic Leukemia: Moving to an Entirely Oral, Chemotherapy-Free Upfront Management Approach
- (2014) A. M. Zeidan et al. CLINICAL CANCER RESEARCH
- Management and treatment results in patients with acute promyelocytic leukaemia (APL) not enrolled in clinical trials
- (2014) Jean Baptiste Micol et al. EUROPEAN JOURNAL OF CANCER
- Randomized Phase III Trial of Retinoic Acid and Arsenic Trioxide Versus Retinoic Acid and Chemotherapy in Patients With Acute Promyelocytic Leukemia: Health-Related Quality-of-Life Outcomes
- (2014) Fabio Efficace et al. JOURNAL OF CLINICAL ONCOLOGY
- Tamibarotene As Maintenance Therapy for Acute Promyelocytic Leukemia: Results From a Randomized Controlled Trial
- (2014) Katsuji Shinagawa et al. JOURNAL OF CLINICAL ONCOLOGY
- Delay in the administration of all-trans retinoic acid and its effects on early mortality in acute promyelocytic leukemia: Final results of a multicentric study in the United States
- (2014) Armin Rashidi et al. LEUKEMIA RESEARCH
- Resistance to Arsenic Therapy in Acute Promyelocytic Leukemia
- (2014) Hong-Hu Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Management of elderly patients with acute promyelocytic leukemia: progress and problems
- (2013) Eva Lengfelder et al. ANNALS OF HEMATOLOGY
- Phase 2 study of arsenic trioxide followed by autologous hematopoietic cell transplantation for relapsed acute promyelocytic leukemia
- (2013) M. Yanada et al. BLOOD
- Outcomes in Patients With Relapsed or Refractory Acute Promyelocytic Leukemia Treated With or Without Autologous or Allogeneic Hematopoietic Stem Cell Transplantation
- (2013) Naveen Pemmaraju et al. Clinical Lymphoma Myeloma & Leukemia
- Optimal approach for high-risk acute promyelocytic leukemia
- (2013) Harry J. Iland et al. CURRENT OPINION IN HEMATOLOGY
- Increased risk of central venous catheter-associated thrombosis in acute promyelocytic leukemia: a single-institution experience
- (2013) Sigal Grisariu et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Oral Tetra-Arsenic Tetra-Sulfide Formula Versus Intravenous Arsenic Trioxide As First-Line Treatment of Acute Promyelocytic Leukemia: A Multicenter Randomized Controlled Trial
- (2013) Hong-Hu Zhu et al. JOURNAL OF CLINICAL ONCOLOGY
- Synergy against PML-RARa: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemia
- (2013) Guilherme Augusto dos Santos et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death
- (2013) Jessica K. Altman et al. LEUKEMIA RESEARCH
- Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
- (2013) Francesco Lo-Coco et al. NEW ENGLAND JOURNAL OF MEDICINE
- All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)
- (2012) H. J. Iland et al. BLOOD
- Gemtuzumab Ozogamicin: Time to Resurrect?
- (2012) Farhad Ravandi et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study
- (2012) Sylvie Castaigne et al. LANCET
- Influence of time to complete remission and duration of all-trans retinoic acid therapy on the relapse risk in patients with acute promyelocytic leukemia receiving AIDA protocols
- (2012) Massimo Breccia et al. LEUKEMIA RESEARCH
- Oral arsenic trioxide-based maintenance regimens for first complete remission of acute promyelocytic leukemia: a 10-year follow-up study
- (2011) W.-Y. Au et al. BLOOD
- Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid
- (2011) J. H. Park et al. BLOOD
- Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome
- (2010) M. A. Sanz et al. BLOOD
- Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group
- (2010) F. Lo-Coco et al. BLOOD
- Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710
- (2010) B. L. Powell et al. BLOOD
- Single Cycle of Arsenic Trioxide–Based Consolidation Chemotherapy Spares Anthracycline Exposure in the Primary Management of Acute Promyelocytic Leukemia
- (2010) Steven D. Gore et al. JOURNAL OF CLINICAL ONCOLOGY
- Therapy-Related Myeloid Neoplasms in Patients With Acute Promyelocytic Leukemia Treated With All-Trans-Retinoic Acid and Anthracycline-Based Chemotherapy
- (2010) Pau Montesinos et al. JOURNAL OF CLINICAL ONCOLOGY
- How I treat acute promyelocytic leukemia
- (2009) M. S. Tallman et al. BLOOD
- Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
- (2008) M. A. Sanz et al. BLOOD
- Acute promyelocytic leukemia: from highly fatal to highly curable
- (2008) Z.-Y. Wang et al. BLOOD
- Effective Treatment of Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid, Arsenic Trioxide, and Gemtuzumab Ozogamicin
- (2008) Farhad Ravandi et al. JOURNAL OF CLINICAL ONCOLOGY
- Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation
- (2008) Rihab Nasr et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation